Humana (HUM) Short Interest Ratio & Short Volume

Short interest is the volume of Humana shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 4,580,000 shares of HUM short. 3.82% of Humana's shares are currently sold short. Learn More on Humana's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HUM shares currently have a short interest ratio of 3.0. Learn More on Humana's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Humana: Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Starboard Value LP, Royal Bank of Canada, Nomura Holdings Inc., Millennium Management LLC, Group One Trading LLC, D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., Capula Management Ltd, Wells Fargo & Company MN, National Bank of Canada FI, JPMorgan Chase & Co., Simplex Trading LLC, Twin Tree Management LP, Hollencrest Capital Management, Garda Capital Partners LP, Fulcrum Asset Management LLP, Allianz Asset Management GmbH, Valeo Financial Advisors LLC, IMC Chicago LLC, Portman Square Capital LLP, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.82% of Humana's floating shares are currently sold short.

Humana saw a decline in short interest in the month of January. As of January 31st, there was short interest totaling 4,580,000 shares, a decline of 11.6% from the previous total of 5,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Humana currently has issued a total of 120,410,000 shares. Some of Humana's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Humana currently has a public float of 120,030,000 shares.

3.82% of Humana's shares are currently sold short. Here is how the short interest of companies compare to Humana: Elevance Health, Inc. (1.22%), The Cigna Group (1.51%), Centene Co. (1.34%), Molina Healthcare, Inc. (1.84%), UnitedHealth Group Incorporated (0.85%), Oscar Health, Inc. (11.06%), Alignment Healthcare, Inc. (8.72%), Clover Health Investments, Corp. (3.01%), Trupanion, Inc. (30.15%), NeueHealth, Inc. (1.38%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling HUM is an investing strategy that aims to generate trading profit from Humana as its price is falling. HUM shares are trading down $14.26 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Humana occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HUM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HUM, twice per month. The most recent reporting period available is January, 31 2025.